Opendata, web and dolomites

MetaboliQs SIGNED

Leveraging room temperature diamond quantum dynamics to enable safe, first-of-its-kind, multimodal cardiac imaging

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MetaboliQs project word cloud

Explore the words cloud of the MetaboliQs project. It provides you a very rough idea of what is the project "MetaboliQs" about.

leader    cvd    realizing    death    positron    electron    appropriate    previously    translate    zurich    quantum    confidently    globally    tissue    grade    huji    newly    class    pet    outcomes    polarization    unachievable    excellence    paramagnetic    diamond    therapy    institutes    expertise    chemical    tools    circumstances    companies    fraunhofer    diseases    world    bruker    emission    cvds    personalized    magnetic    cardiovascular    brings    difficult    sensing    therapeutics    precision    innovative    patients    expert    clinical    eth    sensitive    nv    tum    hyperpolarization    metaboliqs    diagnostics    worldwide    diagnose    unaddressed    inventor    disease    resonance    personalize    accurately    treatment    breakthrough    imaging    nitrogen    iaf    synthetic    centers    quantification    diamonds    continental    medical    die    mri    paving    dynamics    market    people    tomography    first    unmet    conduct    metabolic    fabrication    select    preclinical    hyperpolarized    despite    vacancy    characterization    multidisciplinary    molecular    annually    trials    nvision    commercializing    care   

Project "MetaboliQs" data sheet

The following table provides information about the project.

Coordinator
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. 

Organization address
address: HANSASTRASSE 27C
city: MUNCHEN
postcode: 80686
website: www.fraunhofer.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 6˙667˙801 €
 EC max contribution 6˙667˙801 € (100%)
 Programme 1. H2020-EU.1.2.3. (FET Flagships)
 Code Call H2020-FETFLAG-2018-03
 Funding Scheme RIA
 Starting year 2018
 Duration (year-month-day) from 2018-10-01   to  2021-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) coordinator 1˙500˙172.00
2    NVISION IMAGING TECHNOLOGIES GMBH DE (ULM) participant 1˙430˙937.00
3    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) participant 1˙220˙401.00
4    ELEMENT SIX (UK) LIMITED UK (HARWELL OXFORDSHIRE DIDCOT) participant 960˙290.00
5    EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH CH (ZUERICH) participant 936˙812.00
6    THE HEBREW UNIVERSITY OF JERUSALEM IL (JERUSALEM) participant 390˙387.00
7    BRUKER BIOSPIN GMBH DE (RHEINSTETTEN) participant 228˙800.00

Map

 Project objective

Cardiovascular Diseases (CVDs) are the number 1 cause of death globally: more people die annually from CVDs than from any other cause. Despite emerging diagnostics tools and therapeutics, several areas of significant unmet need remain unaddressed among CVD patients. The ability to personalize cardiovascular medical care and improve outcomes, will require characterization of disease processes at a molecular level. The current state-of-the-art, e.g., Positron emission tomography (PET), does not provide detailed information about the chemical state of the tissue at a molecular level, therefore it remains difficult to accurately diagnose and confidently select appropriate therapy in many circumstances. The MetaboliQs project brings together two areas of European excellence - diamond-based quantum sensing and medical imaging. We will translate a newly developed hyperpolarization method for magnetic resonance imaging (MRI) based on the quantum dynamics of nitrogen-vacancy (NV) centers. This breakthrough quantum technology will enable previously unachievable, highly sensitive quantification of metabolic activity, paving the way for precision diagnostics and better personalized treatment of cardiovascular and other metabolic diseases. For realizing and eventually commercializing the technology, MetaboliQs brings together a world-class multidisciplinary consortium with end to end expertise - leading diamond quantum technology research institutes (Fraunhofer IAF - quantum-grade diamond growth and fabrication, HUJI - quantum sensing) and innovative companies (Element 6 - worldwide leader in synthetic diamonds, NVision - inventor of diamond-based polarization), as well as two expert users of hyperpolarized and cardiovascular MRI (TUM, ETH Zurich - first in continental Europe to conduct clinical trials of hyperpolarized MRI for cardiovascular disease) and the market leader in electron paramagnetic resonance and preclinical MRI (Bruker).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METABOLIQS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METABOLIQS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.3.)

FLAG-ERA III (2018)

The Flagship ERA-NET — FLAG-ERA III

Read More  

SQUARE (2018)

Scalable Rare Earth Ion Quantum Computing Nodes

Read More  

PhoQuS (2018)

Photons for Quantum Simulation

Read More